Abstract |
Previous investigations have demonstrated a marked effect of soy protein on multiple physiological parameters associated with the metabolic syndrome (MS). This preliminary study investigated the physiological effects of soy-based diets on cardiovascular risk in a unique rodent model that reflects early stages of MS. Briefly, lean male SHHF (+/cp) rats were randomly assigned to the following treatment groups: casein (control, C); low- isoflavone (LIS) soy protein isolate; high- isoflavone (HIS) soy protein isolate; or C+ 0.01 % rosiglitazone (CR). Rats were fed for thirty-six weeks. Liver weight, heart weight, total plasma cholesterol, fasting blood glucose were lower in soy-fed animals compared to control (p < 0.01). Body weight, kidney weight, alanine aminotransferase (ALT), fasting plasma insulin, and homeostasis model assessment (HOMA) score were also lower in LIS-fed rodents (p < 0.05) compared to casein treatment. All diet groups exhibited lower urine protein (p < 0.01) and small arteriole content (p < 0.05) compared to controls. LIS feed had a slightly more profound influence on body weight, liver metabolism, and insulin sensitivity. However, both soy diets exhibited marked improvements over a casein-based diet.
|
Authors | J Davis, J Steinle, D A Higginbotham, J Oitker, R G Peterson, W J Banz |
Journal | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
(Horm Metab Res)
Vol. 37
Issue 5
Pg. 309-15
(May 2005)
ISSN: 0018-5043 [Print] Germany |
PMID | 15971155
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Caseins
- Dietary Proteins
- Insulin
- Soybean Proteins
|
Topics |
- Animals
- Body Weight
(drug effects)
- Cardiovascular Diseases
- Caseins
(administration & dosage)
- Diet
- Dietary Proteins
(administration & dosage)
- Insulin
(metabolism)
- Liver
(cytology, metabolism)
- Male
- Myocardium
(cytology, metabolism)
- Rats
- Risk Factors
- Soybean Proteins
(administration & dosage)
|